We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
-1.27%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$283B
AUM Growth
+$27.4B
Cap. Flow
+$30.5B
Cap. Flow %
10.78%
Top 10 Hldgs %
36.77%
Holding
11,338
New
1,654
Increased
4,102
Reduced
3,903
Closed
1,507

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 2.35%
2 Technology 1.76%
3 Financials 1%
4 Communication Services 0.83%
5 Healthcare 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XERS icon
9526
Xeris Biopharma Holdings
XERS
$1.45B
$39K ﹤0.01%
15,934
-14,660
-48% -$42.6K
DMK
9527
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$39K ﹤0.01%
+576
New +$42.1K
JBI.WS
9528
DELISTED
Janus International Group, Inc. Warrants, each exercisable for one share of Common Stock at an exerc
JBI.WS
$39K ﹤0.01%
+11,119
New +$43.3K
ADMA icon
9529
ADMA Biologics
ADMA
$2.22B
$38K ﹤0.01%
33,506
-21,971
-40% -$30.8K
ENSC icon
9530
Ensysce Biosciences
ENSC
$7.99M
$38K ﹤0.01%
+3
New +$58.6K
MDWD icon
9531
MediWound
MDWD
$185M
$38K ﹤0.01%
+1,646
New +$43.9K
QSIAW
9532
DELISTED
Quantum-Si Inc Warrant
QSIAW
$38K ﹤0.01%
18,847
+1,606
+9% +$4.29K
GRCE
9533
Grace Therapeutics
GRCE
$34.7M
$38K ﹤0.01%
+3,153
New +$62.1K
BWACW
9534
DELISTED
BETTER WORLD ACQUISITION CORP. Warrants
BWACW
$38K ﹤0.01%
62,197
-1,325
-2% -$1.08K
MIMO.WS
9535
DELISTED
Airspan Networks Holdings Inc Warrants
MIMO.WS
$38K ﹤0.01%
+50,985
New +$40.5K
PIPP.WS
9536
DELISTED
Pine Island Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
PIPP.WS
$38K ﹤0.01%
44,751
+1,445
+3% +$1.38K
HIPO.WS
9537
DELISTED
Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share
HIPO.WS
$37K ﹤0.01%
+40,106
New +$42.2K
TINV.WS
9538
DELISTED
Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TINV.WS
$37K ﹤0.01%
53,202
-847
-2% -$745
CHR icon
9539
Cheer Holding
CHR
$3.4M
$36K ﹤0.01%
+14
New +$44.7K
MRKR icon
9540
CALL
Marker Therapeutics
MRKR
$18.7M
$36K ﹤0.01%
2,120
-1,440
-40% -$29.5K
DDMXW
9541
DELISTED
DD3 Acquisition Corp. II Warrant
DDMXW
$36K ﹤0.01%
30,483
+465
+2% +$608
KURIW
9542
DELISTED
Alkuri Global Acquisition Corp Warrant
KURIW
$36K ﹤0.01%
25,538
-91
-0.4% -$135
CRBP icon
9543
CALL
Corbus Pharmaceuticals
CRBP
$190M
$35K ﹤0.01%
1,160
-2,540
-69% -$100K
FTFT icon
9544
PUT
Future FinTech Group
FTFT
$1.47M
$35K ﹤0.01%
21
-22
-51% -$44.4K
OGEN icon
9545
Oragenics
OGEN
$2.48M
$35K ﹤0.01%
+31
New +$37.4K
ENSV
9546
DELISTED
Enservco Corp.
ENSV
$35K ﹤0.01%
+24,341
New +$31.1K
BLCT
9547
DELISTED
BlueCity Holdings Limited American Depositary Shares
BLCT
$35K ﹤0.01%
+11,662
New +$57.4K
TACA.WS
9548
DELISTED
Trepont Acquisition Corp I Redeemable Warrants, each whole warrant exercisable for one Class A ordin
TACA.WS
$35K ﹤0.01%
54,473
-3,244
-6% -$2.54K
GCMGW
9549
DELISTED
GCM Grosvenor Inc Warrant
GCMGW
$34K ﹤0.01%
+17,120
New +$29.1K
REVBW icon
9550
Revelation Biosciences Warrant
REVBW
$34K ﹤0.01%
55,285
-4,001
-7% -$2.42K

Similar funds

Jane Street's Q3 2021 Portfolio in Review

As of Q3 2021, Jane Street held 11,338 positions worth $283B, up 11% from $256B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jane Street deployed $30.5B of net new capital in Q3 2021, opening 1,654 new positions and adding to 4,102 existing holdings. Its largest new stake was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.3% of assets, down from 2.5% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares MBS ETF, an estimated $1.01B trimmed.

  • Jane Street's largest Q3 2021 buy was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.
  • Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $1.64B increase.
  • Jane Street's biggest Q3 2021 reduction was iShares MBS ETF, cutting an estimated $1.01B.
  • Jane Street fully exited Vanguard Tax-Exempt Bond Index Fund in Q3 2021, selling an estimated $338M.
  • Jane Street's ten largest holdings make up 37% of its $283B portfolio in Q3 2021.
  • Jane Street opened 1,654 new positions and closed 1,507 in Q3 2021.
  • Jane Street's portfolio value rose 11% quarter-over-quarter to $283B.

Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.